COMP <GO>
ITGR vs TMDX // EV/EBITDA & P/E VALUATION
Integer Holdings Corporation (NYSE) VS. TransMedics Group Inc. (NASDAQ) • 15-METRIC TALLY: ITGR 2
— TMDX 10
▲ EV/EBITDA & P/E VALUATION LEADER: TMDX
LAST: $126.52 (-0.02%) • MKT CAP: $4.30B
valuation
18.3x
LAST: $67.12 (+0.33%) • MKT CAP: $2.33B
valuation
14.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ITGR VS. TMDX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ITGR | TMDX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.00% | 59.90% | -32.90 | TMDX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | 18.10% | -12.10 | TMDX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.3x | 14.6x | +3.70 | TMDX | /valuation <GO> |
| Free Cash Flow Yield | 2.44% | 5.74% | -3.30 | TMDX | /fcf-yield <GO> |
| Operating Margin | 11.90% | 17.90% | -6.00 | TMDX | /operating-margins <GO> |
| Net Profit Margin | 5.50% | 31.40% | -25.90 | TMDX | /net-margins <GO> |
| Revenue Growth (YoY) | 8.00% | 37.10% | -29.10 | TMDX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.91 | 3.50 | -0.59 | TMDX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 28.9 | +30.37 | ITGR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.9x | 10.2x | +28.70 | TMDX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.30B | $2.33B | $1.97B | ITGR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ITGR REV | TMDX REV | ITGR GROSS % | TMDX GROSS % | ITGR FCF | TMDX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.85B | $605.5M | 27.0% | 59.9% | $105.1M | $133.6M |
| FY 2024 | $1.72B | $441.5M | 26.7% | 59.4% | $99.8M | -$80.9M |
| FY 2023 | $1.56B | $241.6M | — | — | $110.2M | -$13.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ITGR // BETA 1.02
TMDX // BETA —